美国
证券交易委员会
华盛顿特区20549

_____________________________________

14A日程安排表

_____________________________________

根据14(a)条的授权代理声明
1934年证券交易法（修正案号）

由登记公司提交		☒
由除注册人以外的某方提交		☐

请勾选适当的框:

☐		初步委托书
☐		仅限委员会使用，机密（根据14a规定允许）-6(e)(2))
☐		最终委托书
☒		明确的附加材料
☐		LETTER TO SHAREHOLDERS OF Sk GROWTH OPPORTUNITIES CORPORATION-12

inmed pharmaceuticals公司。
(根据公司章程规定规定的注册人名称)

___________________________________________________________
(提交代理声明书的人的姓名，如果不是注册人)

支付申报费（选中适当的方框）

☒		不需要费用。
☐		之前用初步材料支付的费用。
☐		www.cstproxy.com-6根据Sk Growth修订和重新修订的章程，会议的实际地点将位于加利福尼亚州帕洛阿图的威尔逊桑西尼古德里奇与罗莎蒂律师事务所的650页米尔路。然而，为了方便股东参与，股东大会将以虚拟会议形式举行，无需亲自参加股东大会。股东将享有与实地会议相同的权利和机会进行投票、提问和参与。-11.

关于于2024年12月18日举行的股东年度大会的代理材料的可用性的重要通知

尊敬的股东：

您收到这份通知是因为inmed pharmaceuticals Inc.（"公司）正在使用通知-and-访问 规定投递其2024年度股东大会的会议材料的通知Meeting”) to its registered and beneficial shareholders. This notice regarding the Meeting is prepared pursuant to the notice-and-access rules under National Instrument 54-101 — Communication with Beneficial Owners of Securities of a Reporting Issuer, National Instrument 51-102 — Continuous Disclosure Obligations根据第14a条规定-16 根据1934年修正案的美国证券交易所法案. 根据通知-and-访问，股东仍会收到一份代理或投票指示表，使他们能够在会议上投票。但是，股东不再会收到会议通知、代理声明和信息通函的纸质副本（“BLAC股东会议”），而是会收到这份通知，其中包含如何访问代理报告、2024年年度报告和代理表格信息（统称“会议材料。”) electronically. The use of this alternative method of delivery is more environmentally responsible as it will reduce paper use and will also reduce the Company’s printing and mailing costs. This notice is not a form for voting. You cannot use this notice to vote your shares. This notice presents only an overview of the more complete information in the Meeting Materials which contain important information and can be accessed online as provided below. Under United States Securities and Exchange Commission rules, you are receiving this notice that the proxy materials for the Meeting are available on the internet. Follow the instructions below to view the materials and vote online or request a copy. The items to be voted on and location of the Meeting are also provided below.

The Company has elected not to use the procedure known as “stratification” in relation to its shareholders under the “notice and access” rules. Stratification occurs when a reporting issuer using the “notice and access” rules provides a paper copy of proxy相关 materials to some, but not all, of its shareholders.

The Meeting will be held in a virtual format on Tuesday, December 18, 2024 at 4:00 p.m. (PST). The Meeting will be conducted via telephone conference. You will not be able to attend the Meeting in person. Only shareholders who own common shares of the Company at the close of business on the record date of October 21, 2024 can submit their votes (not later than 4:00 p.m. (PST), on December 16, 2024, the proxy cut-off date for the meeting), or any adjournment or postponement of the Meeting.

To access the meeting by phone, please use the following conference call dial-in 详细信息:

加拿大/美国免费电话, as applicable, signed on behalf of the Company by its Chief Executive Officer, Chief Financial Officer, President, Executive Vice President, Vice President, Secretary or Chairman of the board of directors of the Company (the “:		+1.844.763.8274
国际长途费用:		+1.647.484.8814

会议将于太平洋标准时间下午4:00准时开始。会议将于会议开始前15分钟开放。

会议的目的是:

1.      为了收到公司的经过审计的财务报表和审计师关于该报表的报告，截至6月结了财政年度 30, 2024.

2.      选举公司在代理声明中提名的董事，任期直至公司下次年度股东大会或者直至选出其继任者为止。请参见代理声明中的“提案2：董事选举”。在代理声明中观看“

3.      任命Marcum LLP为公司即将到来的一年的审计师/独立注册的注册会计师，并授权董事们确定审计师的报酬。请参见代理声明中的“提案3：审计师的任命”。在代理声明中观看“

4.      根据需要在会议上或其任何休会或推迟期间进行进一步处理或其他业务。